Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Exkivity is a targeted drug for the treatment of specific types of non-small cel···【more】
Release date：2024-08-07Recommended：222
Exkivity is an oral capsule drug primarily used for the treatment of patients wi···【more】
Release date：2024-08-07Recommended：260
Exkivity is an innovative, oral, small molecule tyrosine kinase inhibitor (TKI) ···【more】
Release date：2024-08-07Recommended：226
Exkivity offers a new treatment option for NSCLC patients with EGFR exon 20 inse···【more】
Release date：2024-08-07Recommended：219
Capmatinib is a targeted drug manufactured by Novartis for the treatment of adul···【more】
Release date：2024-08-07Recommended：236
Exkivity provides a new treatment option for NSCLC patients with EGFR exon 20 in···【more】
Release date：2024-08-07Recommended：194
Capmatinib inhibits the proliferation and survival of MET-dependent cancer cells···【more】
Release date：2024-08-07Recommended：163
Exkivity is an innovative, oral, small molecule tyrosine kinase inhibitor (TKI) ···【more】
Release date：2024-08-07Recommended：183
Capmatinib is highly selective for c-Met targets, can effectively inhibit the pr···【more】
Release date：2024-08-07Recommended：200
Capmatinib prevents the growth and spread of cancer cells by inhibiting MET tyro···【more】
Release date：2024-08-06Recommended：263
Capmatinib is a targeted therapy for patients with non-small cell lung cancer wi···【more】
Release date：2024-08-06Recommended：262
Capmatinib is an oral drug manufactured by Novartis Pharmaceutical. It is a tyro···【more】
Release date：2024-08-06Recommended：233
